[15] Oral presentation

[O-02] Outcomes of CDK4/6 inhibitors in patients with HR+/HER2- metastatic breast cancer: A retrospective single institution study

*Akane Higami¹, Masahiro Takada¹, Jaxi He¹, Makoto Fujino¹, Yuki Nakkmura¹, Rie Nakagawa¹, Yukiko Inagaki¹, Nobuko Kawaguchi¹, Kosuke Kawaguchi¹, Masahiro Kawashima¹, Yukiko Mori¹, Eiji Suzuki¹, Masakazu Toi¹ (1. Kyoto University Hospital)